Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.635
-0.045 (-2.68%)
Apr 29, 2026, 10:39 AM EDT - Market open
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $111.78 million as of April 29, 2026. Its market cap has decreased by -29.39% in one year.
Market Cap
111.78M
Enterprise Value
57.38M
1-Year Change
-29.39%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since May 29, 2012, Cardiff Oncology's market cap has increased from $56.00M to $111.78M, an increase of 99.60%. That is a compound annual growth rate of 5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 117.60M | -37.88% |
| Dec 31, 2025 | 189.30M | -14.69% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 75.54% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 121.95M |
| InflaRx | 120.73M |
| Vivani Medical | 115.97M |
| Cognition Therapeutics | 114.37M |
| Genelux | 112.26M |
| Verrica Pharmaceuticals | 112.18M |
| Biomea Fusion | 110.62M |
| PepGen | 109.20M |